Kalkine : Biggest Nasdaq Companies by Millennium Management LLC

2 min read | June 03, 2025 02:10 PM PDT | By Team Kalkine Media

Highlights

  • Millennium Management added shares of Immunome, Inc. during the last quarter.
  • Immunome is listed on Nasdaq and falls within healthcare and biotech sectors.
  • The firm holds a notable stake in Immunome based on recent SEC filings.

Millennium Management LLC, (NASDAQ:IMNM) an established entity operating in major financial indexes including Biggest Nasdaq Companies, recorded activity involving shares of Immunome, Inc. Immunome, listed on Nasdaq under the ticker IMNM, operates within the biotechnology sector, focusing on innovative healthcare solutions.

Details on Share Activity

During the final quarter of the previous fiscal year, Millennium Management expanded its stake in Immunome. This movement was documented in official filings with the Securities and Exchange Commission, revealing a substantial amount of shares acquired by the firm. These shares represent a small but meaningful portion of Immunome’s total shares outstanding.

Immunome’s Sector and Market Position

Immunome is part of the biotechnology industry, which often features companies advancing medical research and therapies. Its listing on Nasdaq places it alongside a range of firms contributing to technological and healthcare advancements. The firm’s presence in these indexes reflects its relevance in the market and sector.

Institutional Interest in Immunome

Millennium Management’s recent activity signals engagement with Immunome within institutional portfolios tracked by Nasdaq and the S&P 500 indexes. The firm’s ownership stake is indicative of its interest in the biotechnology sector’s ongoing developments. This engagement is part of broader market trends involving companies focused on medical innovation.

Market Impact

While Immunome’s shares are actively part of market transactions, the company remains positioned among Nasdaq-listed biotechnology (NASDAQ:IMNM) firms, contributing to the sector’s overall dynamics. Engagement by firms like Millennium Management highlights Immunome’s role in ongoing healthcare advancements.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next